Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Cash generated from core business operations
Latest
$-169.25M
↓ 118% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-77.75M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-169.25M | -7.5% |
| 2024 | $-157.41M | -57.6% |
| 2023 | $-99.91M | -24.7% |
| 2022 | $-80.14M | -49.2% |
| 2021 | $-53.72M | +29.1% |
| 2020 | $-75.78M | -15.3% |
| 2019 | $-65.69M | -104.1% |
| 2018 | $-32.19M | -30.8% |
| 2017 | $-24.61M | -30.7% |
| 2016 | $-18.84M | - |